Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24813611.
- Also identified by DOI 10.1016/j.cell.2014.03.026 and PMC identifier 4625837.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mitochondrial dysfunction is a common feature in neurodegeneration and aging. We identify mitochondrial dysfunction in xeroderma pigmentosum group A (XPA), a nucleotide excision DNA repair disorder with severe neurodegeneration, in silico and in vivo. XPA-deficient cells show defective mitophagy with excessive cleavage of PINK1 and increased mitochondrial membrane potential. The mitochondrial abnormalities appear to be caused by decreased activation of the NAD(+)-SIRT1-PGC-1α axis triggered by hyperactivation of the DNA damage sensor PARP-1. This phenotype is rescued by PARP-1 inhibition or by supplementation with NAD(+) precursors that also rescue the lifespan defect in xpa-1 nematodes. Importantly, this pathogenesis appears common to ataxia-telangiectasia and Cockayne syndrome, two other DNA repair disorders with neurodegeneration, but absent in XPC, a DNA repair disorder without neurodegeneration. Our findings reveal a nuclear-mitochondrial crosstalk that is critical for the maintenance of mitochondrial health.
Medical subject headings
- Mitophagy
- Poly(ADP-ribose) Polymerases
- Sirtuin 1
- Xeroderma Pigmentosum
- Xeroderma Pigmentosum Group A Protein